Clinical Trial Update: Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating bevacizumab after chemoradiotherapy for locally advanced lung adenocarcinoma is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lung Adenocarcinoma | Phase 2 | Status: COMPLETED